A mouse model of influenza infection was studied to help define parameters that may affect serodiagnosis of human infections by immunoassays. Antibodies to both type-and subtype-specific influenza A antigens were measured by a solidphase immunofluorometric assay. Dilute mouse sera were added to purified influenza virds that had been covalently bound to polyaminostyrene microbeads, and the bound antibody was detected by fluorescein isothiocyanate-labeled isotype-specific antisera. Results were consistent in that upon exposure of mice by either infection alone or by vaccination after infection, both immunoglobulin M (IgM) and IgG antibodies reactive with newly encountered subtype specific viral antigens were measured. IgG antibody was usually detectable by the solid-phase immunofluorometric assay several days before it could be detected by a hemagglutination inhibition test. Increased levels of antibody of the IgGl, IgG2a, IgG2b, and IgG3 subclasses were also measured during influenza infection. Surprisingly, response to type-specific viral antigens was of the IgG class in primary as well as in secondary exposure. The results suggest that for serodiagnosis of influenza infections by detection of specific IgM antibody, the assay should use subtypespecific antigens.
A mouse model of influenza infection was studied to help define parameters that may affect serodiagnosis of human infections by immunoassays. Antibodies to both type-and subtype-specific influenza A antigens were measured by a solidphase immunofluorometric assay. Dilute mouse sera were added to purified influenza virds that had been covalently bound to polyaminostyrene microbeads, and the bound antibody was detected by fluorescein isothiocyanate-labeled isotype-specific antisera. Results were consistent in that upon exposure of mice by either infection alone or by vaccination after infection, both immunoglobulin M (IgM) and IgG antibodies reactive with newly encountered subtype specific viral antigens were measured. IgG antibody was usually detectable by the solid-phase immunofluorometric assay several days before it could be detected by a hemagglutination inhibition test. Increased levels of antibody of the IgGl, IgG2a, IgG2b, and IgG3 subclasses were also measured during influenza infection. Surprisingly, response to type-specific viral antigens was of the IgG class in primary as well as in secondary exposure. The results suggest that for serodiagnosis of influenza infections by detection of specific IgM antibody, the assay should use subtypespecific antigens.
Improvements in the serological diagnosis of viral infections may be made possible by the introduction of immunoassay procedures to replace biological assays-such as complement fixation and hemagglutination inhibition (HI) The viruses used to infect mice, or as antigens in the IFMA, were grown in 10-to 12-day-old hen eggs by standard procedures (5) . The harvested allantoic fluid used for solid-phase antigen was clarified by lowspeed centrifugation and was stored with 0.1% (wt/vol) NaN3 at 4°C. The virus used for infecting mice or cell cultures was stored at -70°C without preservatives.
Virus used for immunization of mice was grown in roller bottles of MDCK cells which, after infection, were incubated for 36 h in serum-free Eagle minimal essential medium containing gentamicin and 1 ,ug of tolylsulfonyl phenylalanyl chloromethyl ketone trypsin per ml. Cell culture fluid was clarified by low-speed centrifugation and was stored at 4°C with thimerosal (0.01%, wt/vol) until concentrated.
Concentration of virus. Influenza virus used for preparation of the solid-phase antigen was purified by differential and density gradient centrifugation, similarly to a previously described procedure (8) .
Virus for immunizing mice was prepared by pelleting the virus grown in MDCK cell culture for 60 min at about 100,000 x g. This concentrate was adjusted to contain 6 Mouse sera were collected and stored at -20°C until used for serological assays. Sera from groups of five animals were pooled in equal volumes for each data point. IFMA. The IFMA was performed by previously published methods (8a, 14). Mouse serum dilutions were prepared in bulk volumes by using phosphatebuffered saline containing 0.25% trypsin-KI04-treated normal goat serum.
The IFMA titer of a serum was defined as the reciprocal of the dilution (interpolated graphically) that yielded a relative fluorescent intensity value 2 times that obtained in a test with correspondingly diluted serum from an uninfected animal. This (2x background) cutoff value was approximately 10 standard deviations above the mean relative fluorescent intensity from uninfected mouse sera (P < 0.01). In some cases a single serum dilution was used to conserve reagents, and fluorescent intensity values were expressed as the number of standard deviations above background obtained with normal mouse serum.
Anti-mouse Ig conjugates. Evaluation of the potency, specificity, and labeling of the FITC conjugates used in this study will be described in detail separately (Gonchoroff et al., in preparation). Goat or rabbit antimouse sera were purchased from U.S. Biochemicals, Cleveland, Ohio (goat anti-mouse IgG Fc specific); or Litton Bionetics, Kensington, Md. (goat anti-mouse IgGl, IgG2a, and IgG3 and also rabbit anti-mouse IgG2b). IgG fractions were isolated and labeled with FITC. FITC-conjugated goat anti-mouse IgM was purchased from Research Plus Laboratories, Denville, N.J. All conjugates were tested against a panel of 14 individual solid-phase mouse myeloma antigens representing all four subclasses of mouse IgG, IgM, IgA, and kappa and lambda Bence-Jones proteins by using the method of Phillips et al. (15) . The IgG (Fc-specific) conjugate was thus shown to have less than 2.0% cross-reaction with either mu or alpha chains compared with the reaction with gamma chain. The IgMspecific conjugate had less than 5.0%o cross-reactivity with alpha heavy chains. The conjugate had 0.09%o cross-reaction with one IgG2b K myeloma, but 10lo unwanted cross-reaction to a different IgG2b K myeloma (MOPC145). The IgM conjugate, when used at the working dilution, had a relative fluorescent intensity value of 0.420 when reacted with homologous IgM solid-phase antigen beads containing a standard amount of myeloma protein, whereas the IgG (Fcspecific) conjugate had an average relative fluorescent intensity value of 0.540 relative fluorescent intensity units against IgG solid-phase antigens. The IgG subclass specific conjugates used had less than 5.0%o cross-reactivity with heterologous IgG, IgM, or IgA solid-phase antigens. Molar fluorescein/protein ratios were between 3.0 and 4.0 for these conjugates.
The conjugates were diluted to their working titers with 0.25% trypsin-KI04-inactivated normal serum of the same species as that from which the conjugate was derived.
HI tests. HI tests were performed according to established procedures (5) 
RESULTS
Specificity of antibodies detected by solid-phase influenza antigens by IFMA. Four solid-phase antigens were prepared, and their specificities were evaluated in an indirect IFMA using NPand M-specific hybridoma antibodies to determine whether type-specific antigens were exposed ( Table 1 ). As expected, the A/PRJ8/34 and untreated A/Ann Arbor/6/60 solid-phase antigens reacted poorly with both NP-and Mspecific antibodies in the IFMA. Triton N-101 treatment of the solid-phase antigen significantly (P < 0.01) increased the reaction of the A/Ann Arbor/6/60 antigen with both antibodies. The A/ USSR/90/77 solid-phase antigen reacted quite well with the NP-and M-specific antibodies. The reason for availability of exposed typespecific antigens in the A/USSR/90/77 solidphase preparation is unknown. Electron microscopy, however, demonstrated the presence of spontaneously disrupted virus particles with free nucleocapsids in the virus remaining after reaction with polyaminostyrene beads (unpublished data), which has not been seen with other strains.
Primary influenza response as measured by the IFMA. Pools of sera from infected animals and controls were tested in the HI and IFMA by using three antigens ( The presence of IgM immune antibody was verified by sucrose density gradient zonal centrifugation of serum collected from mice 11 days after infection (Fig. 1) . IgM antibody to influenza virus, measured by the IFMA, occurred primarily in the fast-moving 19S zone, whereas IgG activity occurred in the slower-migrating zone. Binding with anti-IgG (Fc-specific) conjugate occurred only in the slower-migrating peak, validating the class specificity of this reagent.
The IgG subclass antibody response of this same set of mice is shown in Table 3 . Titers were not determined because of limited amount of subclass-specific conjugates and mouse sera. By day 10, antibodies of all isotypes of IgG were detected. The highest levels (in terms of fluorescent intensity measurements) were seen for mouse IgG2a and IgG2b.
Antibody class and specificity after secondary stimulation. A group of mice were infected intranasally with egg-grown A/PR/8/34 virus. Then they were inoculated intraperitoneally with MDCK-cell culture grown antigen, thereby minimizing any possible response to host-specific antigens on the viruses.
The mice that were primed and boosted with the same (A/PR/8/34) antigen responded with increased HI titers to A/PR/8/34 ( .33 a Values given are the numbers of standard deviations for the fluorescence intensity with serum samples from infected animals above the mean fluorescence intensity obtained with sera from a group of uninfected animals. Sera were tested at a 1:30 dilution. Data are from duplicate determinations run on the same day.
was also seen when measured with A/USSR/90/ 77 solid-phase antigen that has been shown above to detect type-specific antibodies. In addition a slight rise in IgM and IgG antibody to A/ PR/8/34 solid-phase antigen was observed in these mice that had been infected with A/PR/8/ 34 and boosted with A/Ann Arbor/6/60. The antigenic specificity of these antibodies is not clear. DISCUSSION
To measure antibodies reacting with either the surface glycoproteins, HA and NA, or the typespecific NP and M antigens of influenza A virus, we used different preparations of solid-phase viruses. Based on previous observations with monoclonal antibodies, solid-phase antigens prepared with purified whole virions were expected to react predominantly through their surface glycoproteins. For two of the solid-phase antigens, A/PR/8/34 and (untreated) A/Ann Arbor/6/60, this was substantiated by demonstrating that the antigens exhibited very low binding of monoclonal antibodies specific for NP or M. Triton N-101 treatment of the A/Ann Arbor/6/60 antigen increased the reactivity with NP-and Mspecific monoclonal antibodies, consistent with a previous study (14) . A third antigen, A/USSR/ 90/77, for unknown reasons (but probably due to the unusual lability of purified virions) had substantial reactivity with NP and M protein-specific monoclonal antibodies without Triton N-101 treatment. In most cases the combined use of the different solid-phase antigens enabled us to distinguish between the presence of subtype (i.e., HA or NA)-specific antibodies versus type (i.e., NP or M)-specific antibodies in sera of infected and immunized mice. Although it would be preferable to prepare solid-phase antigens with isolated, purified, subvirion components, such an approach greatly increases the expense and decreases the practicality of the assay for routine use and was not considered justified for the present evaluation of mouse antibody response.
Results were consistent in that, upon exposure of mice by either infection alone or infection followed by vaccination, both IgM and IgG antibody responses were elicited to the subtypespecific antigens of a virus strain when first encountered. The IgM response was not detected earlier than an IgG response in either infected or vaccinated animals. This might reflect either a relative difference in the sensitivity of the assays for quantitating IgM and IgG or, alternatively, might reflect the time sequence of synthesis of IgM and IgG antibodies under the circumstances of immunization that we used.
Antibody response in mice infected with A/ PR/8/34 was detected by IFMA several days before detection of antibodies by HI, confirming that, in general, immunoassay procedures may have a higher level of sensitivity for low levels of antibody than do HI tests (1, 9, 13 (7) . However, for maximum usefulness to measure antibody to subtype-specific determinants, solid-phase whole-virus antigen beads should be standardized for their lack of reactivity with type-specific antigens, for example, by testing them with monoclonal or specific polyclonal antibodies to M and NP as done in this study.
